XBiotech Inc. logo

XBiotech Inc.

XBIT | NASDAQ
Chart Builder DCF Calculator
$2.18
-$0.01 (-0.46%)
At close: Sep 21, 2026, 4:00 PM ET
$2.18
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$66.46M
Enterprise Value
$-43.06M
Beta
0.85
Average Volume
36.66K
Shares Outstanding (Diluted)
30.49M
Shares Change YoY
0%
Institutional Ownership
6.54%
Exchange
NASDAQ
ISIN
CA98400H1029

Price Performance

Price Change 1M
-4.4%
Price Change 3M
-6.4%
Price Change 6M
-7.6%
Price Change YTD
-8.4%
Price Change 1Y
-20.7%
Price Change 3Y
-50.0%
Price Change 5Y
-84.8%
1M CAGR (ann.)
-4.0%
1Y CAGR (ann.)
-21.0%
5Y CAGR (ann.)
-32.5%
All-Time CAGR
-17.6%

Valuation

PE Ratio
-1.47
Forward PE
N/A
PEG Ratio
0.03
Forward PEG
0.03
PS Ratio
N/A
Forward PS
N/A
PB Ratio
0.52
P/FCF Ratio
-1.63
P/Adj. FCF Ratio
-1.61
P/OCF Ratio
-1.64
EV/Sales
N/A
EV/EBIT
1.13
EV/EBITDA
1.00
EV/FCF
1.05
Earnings Yield
-67.9%
FCF Yield
-61.4%
Adj. FCF Yield
-62.2%

Financial Health

Net Cash
$109.53M
Total Debt
$0
Cash & Short-Term Investments
$109.53M
Total Assets
$133.65M
Current Ratio
33.15
Quick Ratio
33.15
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
6.15
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-1.3%

Returns

Return on Assets
-33.8%
Return on Equity
-31.6%
Return on Invested Capital
-37.0%
Return on Capital Employed
-37.0%
Return on Tangible Assets
-33.8%

Historical Growth (CAGR)

Revenue CAGR 3Y
N/A
Revenue CAGR 5Y
-92.4%
Revenue CAGR 10Y
-8.5%
EPS CAGR 3Y
-13.9%
EPS CAGR 5Y
-10.9%
EPS CAGR 10Y
-38.4%
FCF CAGR 3Y
-26.9%
FCF CAGR 5Y
-24.9%
FCF CAGR 10Y
4.8%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Aug 12, 2026
EPS Estimate (next Q)
$0.03
EPS Growth Est (next Q)
-150.0%
Revenue Est (next Q)
$7M
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-40.7M
Free Cash Flow
$-40.84M
Adj. Free Cash Flow
$-41.37M
FCF Per Share
-$1.34
OCF Per Share
-$1.33
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-332K
Operating Income
$-48.22M
EBITDA
$-43.19M
Net Income
$-45.13M
EPS (Diluted)
-$1.48
Revenue / Employee
N/A
Profit / Employee
$-518.77K
Employees
87

© 2026 bestshares.com. All rights reserved.